Intravenous injection of AAV9 carrying human codon-optimized SMN1 at postnatal day 1 recovered most motor function, neuromuscular physiology, and lifespan in SMA mice [77]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.